在癌症诊断预测模型中探索人工智能偏差
Aref Smiley1, C Mahony Reategui-Rivera1, David Villarreal-Zegarra1
1Department of Biomedical Informatics, University of Utah, Salt Lake City, UT 84108, USA.
Cancers
|February 13, 2025
概括
大多数人工智能瘤学研究都表现出偏见和不良报告,未能满足ASCO的要求.
科学领域:
- 在瘤学瘤学.
- 医疗信息学 医疗信息学
- 人工智能的人工智能
背景情况:
- 美国临床瘤学会 (ASCO) 制定了负责在瘤学中使用人工智能 (AI) 的原则.
- 发表的研究中遵守这些原则在很大程度上仍未被评估.
研究的目的:
- 评估存在偏见和研究AI模型癌症诊断研究的质量.
- 评估是否符合ASCO负责的人工智能原则.
- 检查这些因素对后续研究应用的影响.
主要方法:
- 在ASCO信息学期刊上发表的针对癌症诊断的AI预测模型的系统审查.
- 使用与ASCO原则和CREML研究质量检查清单一致的17个偏差标准进行评估.
- 对绩效指标和引用数量的分析.
主要成果:
- 包括9项研究,揭示了常见的偏见:环境,生命过程,上下文,提供者专业知识和隐性偏见.
- 透明度,监督,隐私和以人为中心的AI应用是最不遵守ASCO原则的.
- 只有22%的研究提供了数据访问,CREML检查清单显示了方法和报告的缺陷.
结论:
- 大多数人工智能瘤学研究都表现出偏见和报告缺陷,限制了它们的适用性和可重复性.
- 在遵守ASCO负责任的人工智能原则方面存在重大差距.
- 建议包括提高透明度,数据可访问性和遵守国际指南,以获得可靠的瘤学AI研究.
更多相关视频
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.2K
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
8.9K
相关概念视频
Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer Survival Analysis
321
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
321
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Bias in Epidemiological Studies
139
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
139
